Literature DB >> 7914550

Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released.

J M Casasnovas1, T A Springer.   

Abstract

We have examined the pathway of rhinovirus interaction with soluble intercellular adhesion molecule 1 (sICAM-1). Binding of sICAM-1 to rhinovirus serotypes 3 and 14 gives particles with sedimentation coefficients from 145 to 120S, depending on the amount of sICAM-1 bound. The formation of 120S particles is faster and more extensive at a neutral pH than at an acidic pH. A large number of receptors (> 30) can bind to human rhinovirus 3 without disruption. Disruption by sICAM-1 of rhinovirus that yields 80S particles is strongly temperature dependent and is antagonized by a low pH. Interestingly, sICAM-1 remains bound to the viral capsid after RNA is released, although in smaller amounts than those observed for the native virus. We have found heterogeneity both between and within 80S particle preparations in the VP4 content and number of bound receptors. The ability of the virus to remain bound to its receptor during the uncoating process may facilitate the transport of the viral genome into the cytoplasm in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914550      PMCID: PMC236993     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Internalization of a major group human rhinovirus does not require cytoplasmic or transmembrane domains of ICAM-1.

Authors:  D E Staunton; A Gaur; P Y Chan; T A Springer
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

2.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

3.  Naturally occurring and artificially produced components of three rhinoviruses.

Authors:  B D Korant; K Lonberg-Holm; J Noble; J T Stasny
Journal:  Virology       Date:  1972-04       Impact factor: 3.616

4.  Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1.

Authors:  J M Greve; C P Forte; C W Marlor; A M Meyer; H Hoover-Litty; D Wunderlich; A McClelland
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Preparation and characterization of encephalomyocarditis (EMC) virus.

Authors:  R R Rueckert; M A Pallansch
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Characterization of poliovirus conformational alteration mediated by soluble cell receptors.

Authors:  A Gómez Yafal; G Kaplan; V R Racaniello; J M Hogle
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

7.  Structure of a human rhinovirus complexed with its receptor molecule.

Authors:  N H Olson; P R Kolatkar; M A Oliveira; R H Cheng; J M Greve; A McClelland; T S Baker; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

8.  Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules.

Authors:  S Martin; J M Casasnovas; D E Staunton; T A Springer
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Requirements for entry of poliovirus RNA into cells at low pH.

Authors:  I H Madshus; S Olsnes; K Sandvig
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

10.  Mechanism of entry into the cytosol of poliovirus type 1: requirement for low pH.

Authors:  I H Madshus; S Olsnes; K Sandvig
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

View more
  33 in total

1.  Distinct cellular receptor interactions in poliovirus and rhinoviruses.

Authors:  L Xing; K Tjarnlund; B Lindqvist; G G Kaplan; D Feigelstock; R H Cheng; J M Casasnovas
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

2.  Receptor priming of major group human rhinoviruses for uncoating and entry at mild low-pH environments.

Authors:  Ghasem Nurani; Birgitta Lindqvist; José M Casasnovas
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

4.  Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms.

Authors:  D Schober; P Kronenberger; E Prchla; D Blaas; R Fuchs
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Kinetic models for receptor-catalyzed conversion of coxsackievirus B3 to A-particles.

Authors:  Steven D Carson
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

6.  Extracellular Albumin and Endosomal Ions Prime Enterovirus Particles for Uncoating That Can Be Prevented by Fatty Acid Saturation.

Authors:  Visa Ruokolainen; Aušra Domanska; Mira Laajala; Maria Pelliccia; Sarah J Butcher; Varpu Marjomäki
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

7.  A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.

Authors:  D R Shafren; D T Williams; R D Barry
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  The domain structure of ICAM-1 and the kinetics of binding to rhinovirus.

Authors:  J M Casasnovas; J K Bickford; T A Springer
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Expression of the recombinant anchorless N-terminal domain of mouse hepatitis virus (MHV) receptor makes hamster of human cells susceptible to MHV infection.

Authors:  G S Dveksler; S E Gagneten; C A Scanga; C B Cardellichio; K V Holmes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Structural analysis of human rhinovirus complexed with ICAM-1 reveals the dynamics of receptor-mediated virus uncoating.

Authors:  Li Xing; José M Casasnovas; R Holland Cheng
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.